epidemic hemorrhagic fever

A surveillance network for epidemic hemorrhagic fever has been established for immediate reporting of cases.

It is also known as Korean hemorrhagic fever, epidemic hemorrhagic fever, and nephropathis epidemica.

Green Cross developed the world's first vaccine "Hantavax" against epidemic hemorrhagic fever in 1988 and the world's second treatment "Hunterase" of Hunter syndrome in 2012.

Hantaan, Dobrava, Saaremaa, Seoul, and Puumala are several hantaviruses species that cause HFRS, also known as Korean hemorrhagic fever, epidemic hemorrhagic fever and nephropathis epidemica.